OutSourcing-Pharma.comZelluna names MaSTherCell as CDMO to support immunotherapy developmentOutSourcing-Pharma.comZelluna Immunotherapy has partnered with the CDMO MasSTherCell to develop its T-cell receptor (TCR) adoptive cell therapy platform with cl… Continue reading
Global Stem Cell Technologies and Applications Market 2018-2018 – Visiongain ReportPR Newswire (press release)The global stem cell technologies and applications market is estimated to have reached $12,040 million and is expected to grow at a CAGR of … Continue reading
Newburgh GazetteGlobal Stem Cell Technologies and Applications Market 2018-2018 – Visiongain ReportPR Newswire UK (press release)The global stem cell technologies and applications market is estimated to have reached $12,040 million and is expected to g… Continue reading
|
Meissa Vaccines Appoints Dr. Lawrence Blatt as Chairman of the Board of Directors
PR Newswire (press release) Meissa’s breakthrough technology platform utilizes synthetic biology and reverse genetics to create safer and more effective vaccines. The company is developing vaccines for RSV, parainfluenza virus, human metapneumovirus, and rhinovirus. RSV is a … |